HC Wainwright & Co. Maintains Buy on Gossamer Bio, Raises Price Target to $90

HC Wainwright & Co. analyst Patrick R. Trucchio maintains Gossamer Bio (NASDAQ:GOSS) with a Buy and raises the price target from $2 to $90.